These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 13220378)

  • 21. Synthetic antimalarial drug therapy in lupus erythematosus and polymorphous light eruptions.
    EPSTEIN JH
    Calif Med; 1960 Feb; 92(2):135-8. PubMed ID: 13820499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The treatment of chronic discoid lupus erythematosus with antimalarial drugs.
    RAKATANSKY H
    Bull Tufts N Engl Med Cent; 1959; 5(1):37-44. PubMed ID: 13662831
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of acute disseminated lupus erythematosus (Libman-Sacks' disease) with a synthetic antimalarial].
    REMOUCHAMPS L
    Acta Med Scand; 1956 Jan; 153(3):237-42. PubMed ID: 13301455
    [No Abstract]   [Full Text] [Related]  

  • 24. [The therapy of systemic lupus erythematosus].
    Hiepe F; Burmester GR
    Dtsch Med Wochenschr; 1996 Sep; 121(37):1129-33. PubMed ID: 8925728
    [No Abstract]   [Full Text] [Related]  

  • 25. [Systemic lupus erythematosus: cutaneous/articular injuries].
    Sociedade Brasileira de Reumatologia
    Rev Assoc Med Bras (1992); 2006; 52(6):384-6. PubMed ID: 17242769
    [No Abstract]   [Full Text] [Related]  

  • 26. The Cutaneous Spectrum of Lupus Erythematosus.
    Ribero S; Sciascia S; Borradori L; Lipsker D
    Clin Rev Allergy Immunol; 2017 Dec; 53(3):291-305. PubMed ID: 28752372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Management of systemic lupus erythematosus (LED) and related diseases].
    Munthe E
    Tidsskr Nor Laegeforen; 1973 Mar; 93(8):533-6. PubMed ID: 4697597
    [No Abstract]   [Full Text] [Related]  

  • 28. [Lupus erythematosus and synthetic antimalarials: personal experience with nivaquine, its advantages over quinacrine, in 41 cases].
    GRUPPER C
    Bull Mem Soc Med Hop Paris; 1953 Dec 11-18; 69(32-33):1077-9. PubMed ID: 13141156
    [No Abstract]   [Full Text] [Related]  

  • 29. [Lupus erythematosus and synthetic antimalarials; personal experience with nivaquine, and its advantages over quinacrine, based on 36 cases].
    GRUPPER C
    Bull Soc Fr Dermatol Syphiligr; 1953; 60(5):423-8. PubMed ID: 13150041
    [No Abstract]   [Full Text] [Related]  

  • 30. [Synthetic antimalarials in therapy of chronic evolutive polyarthritis and other collagen diseases].
    BRUCKNER I; STANESCU M; VEREANU I; LICHTIG E; BELIGAN G; ALINESCU R; ION C
    Med Interna (Bucur); 1961 Jul; 13():975-86. PubMed ID: 13873846
    [No Abstract]   [Full Text] [Related]  

  • 31. Dermatologic clinics. 2. Antimalarial drugs in the therapy of lupus erythematosus.
    MERWIN CF; WINKELMANN RK
    Proc Staff Meet Mayo Clin; 1962 Apr; 37():253-68. PubMed ID: 14472922
    [No Abstract]   [Full Text] [Related]  

  • 32. Antimalarial therapy of lupus erythematosus.
    WINKELMANN RK; MERWIN CF; BRUNSTING LA
    Ann Intern Med; 1961 Nov; 55():772-6. PubMed ID: 14007518
    [No Abstract]   [Full Text] [Related]  

  • 33. [Systemic lupus erythematosus].
    Fischer-Betz R; Herzer P; Schneider M
    Dtsch Med Wochenschr; 2005 Oct; 130(43):2451-8; quiz 2459-60, 2461-2. PubMed ID: 16240245
    [No Abstract]   [Full Text] [Related]  

  • 34. [Antimalarials in lupus erythematosus treatment].
    Woźniacka A
    Przegl Lek; 2002; 59(3):179-82. PubMed ID: 12184034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparative data and remote results in therapy of lupus erythematosus with resochin, aminoquinol and other substances].
    DMITRIEVA IN; BELUKHA UK
    Vestn Dermatol Venerol; 1962 Jan; 36():23-30. PubMed ID: 13886713
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of lupus erythematosus with antimalarials: results and incidents of treatment.
    BUREAU ; JARRY ; BARRIERE
    Bull Soc Fr Dermatol Syphiligr; 1954; 61(3):289-91. PubMed ID: 13199644
    [No Abstract]   [Full Text] [Related]  

  • 37. General considerations in the treatment of systemic lupus erythematosus.
    Rothfield NF
    Mayo Clin Proc; 1969 Sep; 44(9):691-6. PubMed ID: 5821139
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of chloroquine phosphate treatment on serum MMP-9 and TIMP-1 levels in patients with systemic lupus erythematosus.
    Lesiak A; Narbutt J; Sysa-Jedrzejowska A; Lukamowicz J; McCauliffe DP; Wózniacka A
    Lupus; 2010 May; 19(6):683-8. PubMed ID: 20064914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic lupus erythematosus.
    Ehrlich GE
    JAMA; 1975 Jun; 232(13):1361-3. PubMed ID: 1173403
    [No Abstract]   [Full Text] [Related]  

  • 40. Systemic lupus erythematosus: causative factors and treatment.
    Morley KD; Hughes GR
    Drugs; 1982 Jun; 23(6):481-8. PubMed ID: 7106013
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.